The Korean Musculoskeletal Tumor Society is promoting fellowship among members through research and academic exchanges while diagnosing and treating orthopedic musculoskeletal tumors (bone tumor, soft tissue tumor, sarcoma cancer, bone cancer).
First of all, I am honored to have the opportunity to serve as the president of KMSTS.
Since founded in 1990, KMSTS has grown into the important part of KOA. This would have been impossible without passion and commitment of the Advisory Committee members, and the challenge and dedication of the KMSTS members. KMSTS has endeavored to treat the musculoskeletal tumor patients and raise the quality of life of patients for the last 29 years. KMSTS has also dedicated to make an academic achievement and its dissemination.
In 2018, we have renamed to KMSTS and tried to ensure the internal stability and expand the scope. By hosting the upcoming 2023 International conference, we could raise our reputation one-step further. Additionally I will try to rationalize the current low insurance price, and to make concrete of our value by increase the relationship between members.
I would like to express my gratitude to the former president, Jung Ryul Kim and secretary Il Kyu Han and all members of the Board of Directors who have tirelessly led KMSTS for the past 1 year.
I wish all members of KMST continued health and success in 2019.